Life ScienceCompany
BioCryst Pharmaceuticals M&A Summary
BioCryst Pharmaceuticals has acquired 2 companies. A total of 2 acquisitions came from private equity firms.
BioCryst Pharmaceuticals’ largest acquisition to date was in 2012, when it acquired Presidio Pharmaceuticals for $101M. BioCryst Pharmaceuticals has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).
BioCryst Pharmaceuticals Business Overview
Where is BioCryst Pharmaceuticals headquartered?
BioCryst Pharmaceuticals is headquartered in Durham, North Carolina.
What is BioCryst Pharmaceuticals’ revenue?
BioCryst Pharmaceuticals disclosed revenue of 331M USD for 2023 and 270M USD for 2022.
How many employees does BioCryst Pharmaceuticals have?
BioCryst Pharmaceuticals has 536 employees.
What sector is BioCryst Pharmaceuticals in?
BioCryst Pharmaceuticals is a life science company.
When was BioCryst Pharmaceuticals founded?
BioCryst Pharmaceuticals was founded in 1986.
M&A Summary
-
M&A Total Activity1
- M&A Buy Activity1
- Total Sectors Invested 1
- Total Countries Invested 1
- M&A Buy/Sell Connections 2